Evidence map›Paper›PMID 22233601›Full record

ArticleAnnals of the rheumatic diseases2012

Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G.

Michelle M A Fernando, Jan Freudenberg, Annette Lee, David Lester Morris, Lora Boteva, Benjamin Rhodes, María Francisca Gonzalez-Escribano, Miguel Angel Lopez-Nevot, Sandra V Navarra, Peter K Gregersen and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 4 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 4 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Lupus · 2023
    Article
  13. Article
  14. Article
  15. Immunogenetics of Lupus Erythematosus.Advances in experimental medicine and biology · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 4 countries.

Michelle M A FernandoDivision of Genetics and Molecular Medicine and Division of Immunology, Infection and Inflammatory Disease, King's College London, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK. michelle.fernando@kcl.ac.uk
Jan Freudenberg
Annette Lee
David Lester Morris
Lora Boteva
Benjamin Rhodes
María Francisca Gonzalez-Escribano
Miguel Angel Lopez-Nevot
Sandra V Navarra
Peter K Gregersen
Javier Martin
IMAGEN
Timothy J Vyse
Guy's Hospital · GBKing's College London · GBNorthwell Health · USFeinstein Institute for Medical Research · USHospital Universitario Virgen de las Nieves · ESHospital Universitario Virgen del Rocío · ESInstituto de Parasitología y Biomedicina "López - Neyra" · ESUniversity of Santo Tomas · PH

Funding

Systemic Lupus Erythematosus and Ulcerative Colitis StudyU19AI067152 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KLARESKOG, LARS · 2005 to 2009
$10.1M
Arthritis Research UK 18239Arthritis Research UK 18544Medical Research Council G0000934NIAID NIH HHS AI067152NIAID NIH HHS U19 AI067152Wellcome TrustWellcome Trust 068545/Z/02Wellcome Trust 076113Wellcome Trust 085475
6 · The paper itself

Abstract

objectivesSystemic lupus erythematosus (SLE) is a chronic multisystem genetically complex autoimmune disease characterised by the production of autoantibodies to nuclear and cellular antigens, tissue inflammation and organ damage. Genome-wide association studies have shown that variants within the major histocompatibility complex (MHC) region on chromosome 6 confer the greatest genetic risk for SLE in European and Chinese populations. However, the causal variants remain elusive due to tight linkage disequilibrium across disease-associated MHC haplotypes, the highly polymorphic nature of many MHC genes and the heterogeneity of the SLE phenotype.

methodsA high-density case-control single nucleotide polymorphism (SNP) study of the MHC region was undertaken in SLE cohorts of Spanish and Filipino ancestry using a custom Illumina chip in order to fine-map association signals in these haplotypically diverse populations. In addition, comparative analyses were performed between these two datasets and a northern European UK SLE cohort. A total of 1433 cases and 1458 matched controls were examined.

resultsUsing this transancestral SNP mapping approach, novel independent loci were identified within the MHC region in UK, Spanish and Filipino patients with SLE with some evidence of interaction. These loci include HLA-DPB1, HLA-G and MSH5 which are independent of each other and HLA-DRB1 alleles. Furthermore, the established SLE-associated HLA-DRB1*15 signal was refined to an interval encompassing HLA-DRB1 and HLA-DQA1. Increased frequencies of MHC region risk alleles and haplotypes were found in the Filipino population compared with Europeans, suggesting that the greater disease burden in non-European SLE may be due in part to this phenomenon.

conclusionThese data highlight the usefulness of mapping disease susceptibility loci using a transancestral approach, particularly in a region as complex as the MHC, and offer a springboard for further fine-mapping, resequencing and transcriptomic analysis.

Indexed as

Genetic Predisposition to DiseaseCase-Control StudiesCell Cycle ProteinsChromosome MappingCohort StudiesEthnicityGenetic MarkersHLA-DP beta-ChainsHLA-G AntigensHumansLupus Erythematosus, SystemicMajor Histocompatibility ComplexPhilippinesPolymorphism, Single NucleotideSpainCell Cycle ProteinsGenetic MarkersHLA-DPB1 antigenHLA-DP beta-ChainsHLA-G AntigensMSH5 protein, human

Identifiers

PMID22233601
PMCPMC3329227
OpenAlexW2122497095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.